Translational and Clinical Oncology – TCO
Dr. Syed Quadri
Syed Quadri (Acting)
TCO
Review Branch Personnel
Review Branch Summary
Will consider applications involving translational and clinical investigations, including clinical trials that encompass cancer prevention, diagnosis, and treatment. Specifically, the TCO branch reviews applications on the translation of cancer research to clinical practice; chemoprevention; the development of biomarkers/signatures for tumor detection and diagnosis; and radiation biology and therapy.
Study Sections
- Cancer Prevention CPSS
- Clinical Oncology CONC
- Molecular Cancer Diagnosis and Classification MCDC
- Radiation Therapeutics and Biology RTB
- Training and Career Development: Translational and Clinical Oncology T37
- Special Emphasis Panel for Biomarkers for Early Cancer Detection TCO (80)
- Special Emphasis Panel for Cancer Therapeutics R21 TCO (81)
- Special Emphasis Panel for Translational and Diagnostic Oncology R21 TCO (82)
- Small Business: Cancer Diagnostics and Treatments TCO (10)
- Small Business: Radiation Therapy, Radiation Biology and Nanoparticle Based Therapeutics TCO (11)
